pillbase.ru

Ezmekly

Active substance: mirdametinib

mirdametinib

Centralised EU authorisationActive

Marketing holder: Merck Europe B.V. 

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • Gomekli
    CAPSULE · MIRDAMETINIB 1 mg/1
    82448-130
    SpringWorks Therapeutics, Inc.
  • Gomekli
    CAPSULE · MIRDAMETINIB 2 mg/1
    82448-260
    SpringWorks Therapeutics, Inc.
  • Gomekli
    TABLET, FOR SUSPENSION · MIRDAMETINIB 1 mg/1
    82448-134
    SpringWorks Therapeutics, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-15c5-7e3b-9ae4-05400b54219e,01a12095-31ff-7156-bba8-8883f4aeaee5,01a12097-7d16-723f-b74d-be6ee6b7f993;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006460
Registration status
Active
ATC code
L01EE
Sources
  • product · EMA · EMEA/H/C/006460 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006460 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006460 · Verified 2026-10-09